Finance

Beta
Lists
9627:TADAWUL
Twareat Medical Care Company SCJSC
SAR 8.29
0.00%
(0.00) 1D
Jun 3, 2:19:42 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9627...
Mkt. cap
364.40M
Avg. vol.
3.27K
Volume
26.00
52-wk high
SAR 19.90
52-wk low
SAR 7.40
EPS
-SAR 0.26
Shares outstanding
22.11M
No. of employees
561
Mkt. cap
364.40M
Avg. vol.
3.27K
Volume
26.00
52-wk high
SAR 19.90
52-wk low
SAR 7.40
EPS
-SAR 0.26
Shares outstanding
22.11M
No. of employees
561
News stories
From sources across the web
About Twareat Medical Care Company SCJSC
CEO-
Employees561
Founded2010
Headquarters-
SectorHealth care provider
Websitetwareat.com
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
45.36M
45.36M
46.19M
46.19M
Cost of goods sold
32.14M
32.14M
37.94M
37.94M
Cost of revenue
32.14M
32.14M
37.94M
37.94M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.38M
10.38M
7.42M
7.42M
Operating expense
9.72M
9.72M
15.48M
15.48M
Total operating expenses
41.86M
41.86M
53.42M
53.42M
Operating income
3.50M
3.50M
-7.23M
-7.23M
Other non operating income
7.19K
7.19K
-20.06K
-20.06K
EBT including unusual items
3.07M
3.07M
-7.93M
-7.93M
EBT excluding unusual items
3.07M
3.07M
-7.93M
-7.93M
Income tax expense
304.38K
304.38K
-9.87K
-9.87K
Effective tax rate
9.92%
9.92%
0.12%
0.12%
Other operating expenses
-
-
-
-
Net income
2.76M
2.76M
-7.92M
-7.92M
Net profit margin
6.09%
6.09%
-17.15%
-17.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-443.57K
-443.57K
-685.55K
-685.55K
Net interest expenses
-443.57K
-443.57K
-685.55K
-685.55K
Depreciation and amortization charges
-
-
-
-
EBITDA
4.62M
4.62M
-6.09M
-6.09M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer